Naringenin inhibits the growth ofDictyosteliumand MDCK-derived cysts in a TRPP2 (polycystin-2)-dependent manner

The Concise Guide to PHARMACOLOGY 2013/14: Overview

(2013) Stephen P.H. Alexander et al.   BRITISH JOURNAL OF PHARMACOLOGY

TRP Channels as Therapeutic Targets in Kidney Disease and Hypertension

(2013) Paolo Mene et al.   CURRENT TOPICS IN MEDICINAL CHEMISTRY

Natural Products for Cancer-Targeted Therapy: Citrus Flavonoids as Potent Chemopreventive Agents

(2012) Edy Meiyanto et al.   Asian Pacific Journal of Cancer Prevention

Flavonoids, a ubiquitous dietary phenolic subclass, exert extensive in vitro anti-invasive and in vivo anti-metastatic activities

(2012) Chia-Jui Weng et al.   CANCER AND METASTASIS REVIEWS

The Rac GEF ZizB regulates development, cell motility and cytokinesis in Dictyostelium

(2012) N. K. Pakes et al.   JOURNAL OF CELL SCIENCE

NIH Image to ImageJ: 25 years of image analysis

(2012) Caroline A Schneider et al.   NATURE METHODS

Tolvaptan in Patients with Autosomal Dominant Polycystic Kidney Disease

(2012) Vicente E. Torres et al.   NEW ENGLAND JOURNAL OF MEDICINE

Structural Interaction and Functional Regulation of Polycystin-2 by Filamin

(2012) Qian Wang et al.   PLoS One

Fluid transport and cystogenesis in autosomal dominant polycystic kidney disease

(2011) Sara Terryn et al.   BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE

The antiepileptic drug valproic acid and other medium-chain fatty acids acutely reduce phosphoinositide levels independently of inositol in Dictyostelium

(2011) P. Chang et al.   Disease Models & Mechanisms

The flavonone naringenin inhibits chloride secretion in isolated colonic epithelia

(2011) Danielle Collins et al.   EUROPEAN JOURNAL OF PHARMACOLOGY

Identifying an uptake mechanism for the antiepileptic and bipolar disorder treatment valproic acid using the simple biomedical model Dictyostelium

(2011) N. Terbach et al.   JOURNAL OF CELL SCIENCE

Investigating the Effect of Emetic Compounds on Chemotaxis in Dictyostelium Identifies a Non-Sentient Model for Bitter and Hot Tastant Research

(2011) Steven Robery et al.   PLoS One

Activating AMP-activated protein kinase (AMPK) slows renal cystogenesis

(2011) V. Takiar et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Calcium-mediated mechanisms of cystic expansion

(2010) Shakila Abdul-Majeed et al.   BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE

Polycystic kidney disease: Pathogenesis and potential therapies

(2010) Vinita Takiar et al.   BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE

Apigenin and naringenin suppress colon carcinogenesis through the aberrant crypt stage in azoxymethane-treated rats

(2010) Tety Leonardi et al.   EXPERIMENTAL BIOLOGY AND MEDICINE

The cell biology of polycystic kidney disease

(2010) Hannah C. Chapin et al.   JOURNAL OF CELL BIOLOGY

High Resolution Tracking of Cell Membrane Dynamics in Moving Cells: an Electrifying Approach

(2010) R.A. Tyson et al.   Mathematical Modelling of Natural Phenomena

Strategies to Inhibit Cyst Formation in ADPKD

(2008) J. P. Calvet   Clinical Journal of the American Society of Nephrology

Polycystin-2 down-regulates cell proliferation via promoting PERK-dependent phosphorylation of eIF2α

(2008) Genqing Liang et al.   HUMAN MOLECULAR GENETICS

Small-Molecule CFTR Inhibitors Slow Cyst Growth in Polycystic Kidney Disease

(2008) B. Yang et al.   JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY

Neutral red uptake assay for the estimation of cell viability/cytotoxicity

(2008) Guillermo Repetto et al.   Nature Protocols

Cancer phytotherapeutics: role for flavonoids at the cellular level

(2008) Anup Kale et al.   PHYTOTHERAPY RESEARCH

Cellular Mechanisms Underlying the Laxative Effect of Flavonol Naringenin on Rat Constipation Model

(2008) Zi-Huan Yang et al.   PLoS One

(+/−)-Naringenin as large conductance Ca2+-activated K+ (BKCa) channel opener in vascular smooth muscle cells

(2006) S Saponara et al.   BRITISH JOURNAL OF PHARMACOLOGY